526139-BOM

Transgene Biotek Ltd.

3.00+0.0 (+0.67%)
27 Jul, 12:00 AM

Annual Reports and Financial Documents

Transgene Biotek Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Transgene Biotek Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  • Board Meeting23 Jul 2026
    Board Meeting Intimation for Intimation Of The Board Meeting.
    Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
  • 57 (4) : Prior intimation to the beginning of the quarter22 Jul 2026
    Compliance-57 (4) : Prior intimation to the beginning of the quarter
    Compliance - 57(4)
  • Reg. 32 (1), (3) - Statement of Deviation & Variation22 Jul 2026
    Statement Of Deviation & Variation
    Statement of Deviation & Variation
  • 57 (5) : intimation after the end of quarter22 Jul 2026
    Compliance-57 (5) : intimation after the end of quarter
    Compliance -57 (5)
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliances - Certificate under Reg. 74(5) of SEBI
  • Closure of Trading Window20 Jun 2026
    Closure of Trading Window
    Closure of Trading Window
  • Newspaper Publication2 Jun 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Advertisement of Financial Results under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015.
  • Outcome of Board Meeting29 May 2026
    Board Meeting Outcome for Outcome Of Board Meeting And Submission Of Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31, 2026
    This has reference to our letter dated May 13, 2026, The Board of Directors of the Company at their meeting held on May 29, 2026 have resolved as follows: Pursuant to Regulation 33 of ....
  • Board Meeting15 May 2026
    Board Meeting Intimation for Intimation Of The Board Meeting Of The Company -
    Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve To Consider and approve the ....
  • Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A13 Apr 2026
    Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
    <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
  • Reg. 32 (1), (3) - Statement of Deviation & Variation13 Apr 2026
    Intimation Of Non-Applicability Of Regulation 32(1) Of SEBI Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Quarter Ended On 31St March 2026.
    Non-Applicability of Regulation 32(1) of SEBI.
  • 57 (4) : Prior intimation to the beginning of the quarter13 Apr 2026
    Compliance-57 (4) : Prior intimation to the beginning of the quarter
    Compliance - 57 (4)
  • 57 (5) : intimation after the end of quarter13 Apr 2026
    Compliance-57 (5) : intimation after the end of quarter
    Non-Applicability of Reg -57 (5) of SEBI LODR Regulations, 2015.
  • Reg. 7(3) – Compliance Certificate (RTA & Compliance Officer)13 Apr 2026
    Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015.
    Compliance certificate 7(3)
  • Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201813 Apr 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    Compliances Certificate under 74 (5) of SEBI
  • Closure of Trading Window24 Mar 2026
    Closure of Trading Window
    Closure of Trading Window
  • Newspaper Publication17 Feb 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication
  • Outcome of Board Meeting13 Feb 2026
    Board Meeting Outcome for Outcome Of Board Meeting
    Dear Sir/Madam, This has reference to our letter dated January 28 2026. 1) The Board has considered and approved the unaudited Consolidated & Stand-alone Financial Results of the ....
  • General3 Feb 2026
    Declaration Under Clause 36 Of Listing Agreement With BSE
    General Announcements
  • Board Meeting28 Jan 2026
    Board Meeting Intimation for Intimation Of The Board Meeting To Be Held On Friday, 13Th February, 2026
    Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve 1) To consider and approve ....

Frequently Asked Questions

Where can I download the annual report of Transgene Biotek Ltd.?
Annual reports of Transgene Biotek Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Transgene Biotek Ltd.?
Quarterly earnings results and presentations of Transgene Biotek Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Transgene Biotek Ltd. publish earnings call transcripts?
Earnings call transcripts of Transgene Biotek Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Transgene Biotek Ltd.?
Investor presentations and annual day presentations of Transgene Biotek Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Transgene Biotek Ltd.?
Corporate announcements and regulatory filings of Transgene Biotek Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Transgene Biotek Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Transgene Biotek Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Transgene Biotek Ltd.?
The ISIN (International Securities Identification Number) of Transgene Biotek Ltd. is INE773D01018. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Transgene Biotek Ltd. listed?
Transgene Biotek Ltd. is listed on NSE and BSE. The NSE symbol is 526139-BOM and the BSE code is -.
Where can I find the shareholding pattern of Transgene Biotek Ltd.?
The quarterly shareholding pattern of Transgene Biotek Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Transgene Biotek Ltd. on Sharpely?
Share price data for Transgene Biotek Ltd. is updated as of 27 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.